ENTITY

Jiangsu Hengrui Pharmaceuticals (1276 HK)

148
Analysis
Health CareChina
Jiangsu Hengrui Pharmaceuticals Co.,Ltd develops, manufactures, and markets medicines and medicine packing materials. The Company produces anti-tumor medicines, pain-killers, anti-infection medicines, aluminum foils, and other related products. Jiangsu Hengrui Pharmaceuticals conducts business in China, America, Japan, Korea, Europe, and Australia.
more
09 Jul 2025 07:30

HK Strategy: How to Play the Future H IPOs of the As

​H-share IPOs of A-shares have seen a 30.2% increase in share prices YTD, with a growth outlook driving performance and narrowing H-A discounts....

Logo
542 Views
Share
bullishLens Technology
09 Jul 2025 05:55

Lens Technology A/H Trading - Decent Demand, Helped by A-Share Rally

Lens Technology (300433 CH), a precision manufacturing solution provider, raised around US$700m in its H-share listing. In this note, we talk about...

Logo
1.2k Views
Share
bullishLens Technology
08 Jul 2025 23:40

Lens Technology H Share Listing (6613 HK): Trading Debut

Lens had the fourth-highest international oversubscription rates among recent large AH listings. The AH discount is attractive in part due to the...

Logo
537 Views
Share
06 Jul 2025 10:10

A-H Premium Weekly (Jul 4th): ICBC, Angang Steel, Datang Intl Power Gen, CMB, China Zheshang Bank

We analyzed A-H premium changes in the past week and highlight A-H premium changes for ICBC, Angang Steel, Datang Intl Power Gen, CMB, China...

Logo
626 Views
Share
04 Jul 2025 07:44

Anjoy Foods Group A/H Trading - Cheap Price but Sluggish Demand

Anjoy Foods Group (2648 HK), a quick-frozen food company in China,  raised around US$350m in its H-share listing. In this note, we talk about the...

Logo
519 Views
Share
x